The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was $34.25 for the day, up 2.95% from the previous closing price of $33.27. In other words, the price has increased by $2.95 from its previous closing price. On the day, 0.65 million shares were traded. SUPN stock price reached its highest trading level at $34.415 during the session, while it also had its lowest trading level at $33.57.
Ratios:
Our analysis of SUPN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.22. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Jefferies Upgraded its Hold to Buy on April 13, 2021, whereas the target price for the stock was revised from $25 to $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 02 ’24 when TAMI TILLOTSON MARTIN bought 4,000 shares for $29.02 per share.
TAMI TILLOTSON MARTIN bought 3,100 shares of SUPN for $90,856 on Aug 01 ’24. On Jul 31 ’24, another insider, TAMI TILLOTSON MARTIN, who serves as the Former Officer of the company, bought 5,000 shares for $30.13 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1887360000 and an Enterprise Value of 1526146176. As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 387.88, and their Forward P/E ratio for the next fiscal year is 17.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 229.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.00 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 2.422 whereas that against EBITDA is 12.147.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $35.44, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is 20.56%, while the 200-Day Moving Average is calculated to be 18.83%.
Shares Statistics:
SUPN traded an average of 619.30K shares per day over the past three months and 677860 shares per day over the past ten days. A total of 54.72M shares are outstanding, with a floating share count of 52.76M. Insiders hold about 4.26% of the company’s shares, while institutions hold 107.62% stake in the company. Shares short for SUPN as of 1722384000 were 6161942 with a Short Ratio of 9.95, compared to 1719532800 on 6123573. Therefore, it implies a Short% of Shares Outstanding of 6161942 and a Short% of Float of 17.03.
